|
JPH0680077B2
(ja)
|
1985-02-08 |
1994-10-12 |
サントリー株式会社 |
プロリンエンドペプチダ−ゼインヒビタ−活性を有する新規ペプチド化合物
|
|
US4816444A
(en)
|
1987-07-10 |
1989-03-28 |
Arizona Board Of Regents, Arizona State University |
Cell growth inhibitory substance
|
|
US4879278A
(en)
|
1989-05-16 |
1989-11-07 |
Arizona Board Of Regents |
Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
|
|
US5010099A
(en)
|
1989-08-11 |
1991-04-23 |
Harbor Branch Oceanographic Institution, Inc. |
Discodermolide compounds, compositions containing same and method of preparation and use
|
|
US4939168A
(en)
|
1989-08-11 |
1990-07-03 |
Harbor Branch Oceanographics Institution, Inc. |
Discodermolide compounds, compositions containing same and methods of preparation and use
|
|
JPH04208299A
(ja)
|
1990-11-30 |
1992-07-29 |
Ajinomoto Co Inc |
プロリルエンドペプチターゼ阻害ペプチド
|
|
EP0598129B1
(en)
|
1991-08-09 |
2000-03-22 |
Teikoku Hormone Mfg. Co., Ltd. |
Novel tetrapeptide derivative
|
|
US5721268A
(en)
|
1991-09-23 |
1998-02-24 |
Florida State University |
C7 taxane derivatives and pharmaceutical compositions containing them
|
|
US5399726A
(en)
|
1993-01-29 |
1995-03-21 |
Florida State University |
Process for the preparation of baccatin III analogs bearing new C2 and C4 functional groups
|
|
US5990325A
(en)
|
1993-03-05 |
1999-11-23 |
Florida State University |
Process for the preparation of 9-desoxotaxol, 9-desoxobaccatin III and analogs thereof
|
|
US5714513A
(en)
|
1991-09-23 |
1998-02-03 |
Florida State University |
C10 taxane derivatives and pharmaceutical compositions
|
|
US6011056A
(en)
|
1991-09-23 |
2000-01-04 |
Florida State University |
C9 taxane derivatives and pharmaceutical compositions containing them
|
|
US5728725A
(en)
|
1991-09-23 |
1998-03-17 |
Florida State University |
C2 taxane derivaties and pharmaceutical compositions containing them
|
|
IT1254515B
(it)
|
1992-03-06 |
1995-09-25 |
Indena Spa |
Tassani di interesse oncologico, loro metodo di preparazione ed uso
|
|
US5831002A
(en)
|
1992-05-20 |
1998-11-03 |
Basf Aktiengesellschaft |
Antitumor peptides
|
|
US5635483A
(en)
|
1992-12-03 |
1997-06-03 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Tumor inhibiting tetrapeptide bearing modified phenethyl amides
|
|
IT1261667B
(it)
|
1993-05-20 |
1996-05-29 |
|
Tassano ad attivita' antitumorale.
|
|
US5955423A
(en)
|
1993-12-21 |
1999-09-21 |
The University Of Hawaii |
Cryptophycins
|
|
US5952298A
(en)
|
1993-12-21 |
1999-09-14 |
The University Of Hawaii |
Cryptophycins
|
|
US5504191A
(en)
|
1994-08-01 |
1996-04-02 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory pentapeptide methyl esters
|
|
US5530097A
(en)
|
1994-08-01 |
1996-06-25 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory peptide amides
|
|
US5521284A
(en)
|
1994-08-01 |
1996-05-28 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory pentapeptide amides and esters
|
|
US6500858B2
(en)
|
1994-10-28 |
2002-12-31 |
The Research Foundation Of The State University Of New York |
Taxoid anti-tumor agents and pharmaceutical compositions thereof
|
|
US6100411A
(en)
|
1994-10-28 |
2000-08-08 |
The Research Foundation Of State University Of New York |
Taxoid anti-tumor agents and pharmaceutical compositions thereof
|
|
JPH10508022A
(ja)
|
1994-10-28 |
1998-08-04 |
ザ リサーチ ファウンデーション オブ ステート ユニバーシティ オブ ニューヨーク |
タキソイド誘導体、それらの製造、およびそれらの抗腫瘍薬としての使用
|
|
US6458976B1
(en)
|
1994-10-28 |
2002-10-01 |
The Research Foundation Of State University Of New York |
Taxoid anti-tumor agents, pharmaceutical compositions, and treatment methods
|
|
JPH09509431A
(ja)
|
1994-11-04 |
1997-09-22 |
フアルマシア・エツセ・ピー・アー |
タキサン誘導体
|
|
US5473057A
(en)
|
1994-11-09 |
1995-12-05 |
The Regents Of The University Of California |
Eleutherobin and analogs thereof
|
|
US5599902A
(en)
|
1994-11-10 |
1997-02-04 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Cancer inhibitory peptides
|
|
US5580899A
(en)
|
1995-01-09 |
1996-12-03 |
The Liposome Company, Inc. |
Hydrophobic taxane derivatives
|
|
US6156535A
(en)
|
1995-08-04 |
2000-12-05 |
University Of Ottawa |
Mammalian IAP gene family, primers, probes, and detection methods
|
|
US5681847A
(en)
|
1995-12-05 |
1997-10-28 |
Harbor Branch Oceanographic Institution, Inc. |
Methods of using discodermolide compounds
|
|
FI101923B
(fi)
|
1995-12-05 |
1998-09-15 |
Nokia Telecommunications Oy |
Puheenvuorojen jakaminen suorakanavalla liikennöiville matkaviestimill e
|
|
US5767297A
(en)
|
1997-02-05 |
1998-06-16 |
Ensuiko Sugar Refining Co., Ltd. |
Taxoid derivative and method of producing thereof
|
|
US6441025B2
(en)
|
1996-03-12 |
2002-08-27 |
Pg-Txl Company, L.P. |
Water soluble paclitaxel derivatives
|
|
AU735900B2
(en)
|
1996-03-12 |
2001-07-19 |
Pg-Txl Company, L.P. |
Water soluble paclitaxel prodrugs
|
|
US6133437A
(en)
|
1997-02-13 |
2000-10-17 |
Apoptogen, Inc. |
Modulation of IAPs for the treatment of proliferative diseases
|
|
IT1283633B1
(it)
|
1996-05-10 |
1998-04-23 |
Indena Spa |
Derivati tassanici loro sintesi e formulazioni che li contengono
|
|
US5919815A
(en)
|
1996-05-22 |
1999-07-06 |
Neuromedica, Inc. |
Taxane compounds and compositions
|
|
CA2259977C
(en)
|
1996-07-15 |
2005-06-28 |
Kabushiki Kaisha Yakult Honsha |
Taxane derivatives and drugs containing the same
|
|
US5939527A
(en)
|
1996-07-30 |
1999-08-17 |
Basf Aktiengesellschaft |
Tetrapeptides as antitumor agents
|
|
US5741892A
(en)
|
1996-07-30 |
1998-04-21 |
Basf Aktiengesellschaft |
Pentapeptides as antitumor agents
|
|
US5821263A
(en)
|
1996-08-26 |
1998-10-13 |
Bristol-Myers Squibb Company |
Sulfenamide taxane derivatives
|
|
US6242469B1
(en)
|
1996-12-03 |
2001-06-05 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto, analogues and uses thereof
|
|
US6441186B1
(en)
|
1996-12-13 |
2002-08-27 |
The Scripps Research Institute |
Epothilone analogs
|
|
US6380394B1
(en)
|
1996-12-13 |
2002-04-30 |
The Scripps Research Institute |
Epothilone analogs
|
|
NZ337195A
(en)
|
1997-02-25 |
2001-05-25 |
Biotechnolog Forschung Gmbh |
Epothilones with a modified side chain
|
|
US5886025A
(en)
|
1997-03-06 |
1999-03-23 |
Baylor University |
Anti-mitotic agents which inhibit tubulin polymerization
|
|
US5965537A
(en)
|
1997-03-10 |
1999-10-12 |
Basf Aktiengesellschaft |
Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
|
|
US6103698A
(en)
|
1997-03-13 |
2000-08-15 |
Basf Aktiengesellschaft |
Dolastatin-15 derivatives in combination with taxanes
|
|
FR2761990B1
(fr)
|
1997-04-10 |
1999-06-25 |
Pf Medicament |
Derives halogenes antimitotiques d'alcaloides de vinca
|
|
US6605599B1
(en)
|
1997-07-08 |
2003-08-12 |
Bristol-Myers Squibb Company |
Epothilone derivatives
|
|
US6143721A
(en)
|
1997-07-18 |
2000-11-07 |
Basf Aktiengesellschaft |
Dolastatin 15 derivatives
|
|
AU9340998A
(en)
|
1997-08-09 |
1999-03-01 |
Schering Aktiengesellschaft |
New epothilone derivatives, method for producing same and their pharmaceutical use
|
|
JPH1192468A
(ja)
|
1997-09-17 |
1999-04-06 |
Yakult Honsha Co Ltd |
新規なタキサン誘導体
|
|
DE69729128T2
(de)
|
1997-10-08 |
2005-04-28 |
Bio Research Corporation Of Yokohama, Yokohama |
Taxoid-derivate und verfahren zu ihrer herstellung
|
|
US5965718A
(en)
|
1997-10-24 |
1999-10-12 |
The Scripps Research Institute |
Analogs of sarcodictyin and eleutherobin
|
|
AU758418B2
(en)
|
1997-12-19 |
2003-03-20 |
Kabushiki Kaisha Yakult Honsha |
Taxane derivatives
|
|
US6302838B1
(en)
|
1998-02-25 |
2001-10-16 |
Novartis Ag |
Cancer treatment with epothilones
|
|
US6498257B1
(en)
|
1998-04-21 |
2002-12-24 |
Bristol-Myers Squibb Company |
2,3-olefinic epothilone derivatives
|
|
US6399638B1
(en)
|
1998-04-21 |
2002-06-04 |
Bristol-Myers Squibb Company |
12,13-modified epothilone derivatives
|
|
US6258841B1
(en)
|
1998-06-29 |
2001-07-10 |
Parker Hughes Institute |
Tubulin binding compounds (COBRA)
|
|
US5985837A
(en)
|
1998-07-08 |
1999-11-16 |
Basf Aktiengesellschaft |
Dolastatin 15 derivatives
|
|
US6127406A
(en)
|
1998-10-09 |
2000-10-03 |
Harbor Branch Oceanographic Institution, Inc. |
Discodermolide compounds and methods of use
|
|
EP1135470A2
(en)
|
1998-11-20 |
2001-09-26 |
Kosan Biosciences, Inc. |
Recombinant methods and materials for producing epothilone and epothilone derivatives
|
|
US6433187B1
(en)
|
1998-12-17 |
2002-08-13 |
Tularik Inc. |
Certain polycyclic compounds useful as tubulin-binding agents
|
|
EP1140944B1
(en)
|
1998-12-22 |
2003-08-27 |
Novartis AG |
Epothilone derivatives and their use as antitumor agents
|
|
CZ20012951A3
(cs)
|
1999-02-18 |
2001-11-14 |
Schering Aktiengesellschaft |
16-Halogensubstituované deriváty epothilonu, způsoby jejich výroby a jejich farmaceutické pouľití
|
|
ATE254615T1
(de)
|
1999-02-22 |
2003-12-15 |
Biotechnolog Forschung Gmbh |
C-21 modifizierte epothilone
|
|
US6291684B1
(en)
|
1999-03-29 |
2001-09-18 |
Bristol-Myers Squibb Company |
Process for the preparation of aziridinyl epothilones from oxiranyl epothilones
|
|
US6323315B1
(en)
|
1999-09-10 |
2001-11-27 |
Basf Aktiengesellschaft |
Dolastatin peptides
|
|
US6110691A
(en)
|
2000-01-06 |
2000-08-29 |
Board Of Regents, The University Of Texas System |
Activators of caspases
|
|
US6414015B1
(en)
|
2000-01-28 |
2002-07-02 |
Utah State University |
Laulimalide microtubule stabilizing agents
|
|
WO2001062239A2
(en)
|
2000-02-24 |
2001-08-30 |
Harbor Branch Oceanographic Institution, Inc. |
Novel compositions and uses of dictyostatin compounds
|
|
DE60108359T2
(de)
|
2000-03-01 |
2005-12-22 |
Harbor Branch Oceanographic Institution, Inc., Fort Pierce |
Biologisch wirksame, analoge verbindungen von discodermoliden
|
|
US6362217B2
(en)
|
2000-03-17 |
2002-03-26 |
Bristol-Myers Squibb Company |
Taxane anticancer agents
|
|
US6489314B1
(en)
|
2001-04-03 |
2002-12-03 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
|
US6589968B2
(en)
|
2001-02-13 |
2003-07-08 |
Kosan Biosciences, Inc. |
Epothilone compounds and methods for making and using the same
|
|
AU2001266583A1
(en)
|
2000-05-26 |
2001-12-11 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
|
UA75365C2
(en)
|
2000-08-16 |
2006-04-17 |
Bristol Myers Squibb Co |
Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon
|
|
US6608026B1
(en)
|
2000-08-23 |
2003-08-19 |
Board Of Regents, The University Of Texas System |
Apoptotic compounds
|
|
US6624317B1
(en)
|
2000-09-25 |
2003-09-23 |
The University Of North Carolina At Chapel Hill |
Taxoid conjugates as antimitotic and antitumor agents
|
|
US6992063B2
(en)
|
2000-09-29 |
2006-01-31 |
The Trustees Of Princeton University |
Compositions and method for regulating apoptosis
|
|
WO2002030959A2
(en)
|
2000-10-13 |
2002-04-18 |
Abbott Laboratories |
Peptides derived from smac (diablo) and methods of use therefor
|
|
CA2436195A1
(en)
|
2001-02-09 |
2002-08-22 |
Kosan Biosciences, Inc. |
Laulimalide derivatives
|
|
US6893859B2
(en)
|
2001-02-13 |
2005-05-17 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
|
CN1610549A
(zh)
|
2001-02-20 |
2005-04-27 |
布里斯托尔-迈尔斯斯奎布公司 |
用于治疗难治肿瘤的埃坡霉素衍生物
|
|
US20030083263A1
(en)
|
2001-04-30 |
2003-05-01 |
Svetlana Doronina |
Pentapeptide compounds and uses related thereto
|
|
US20030023082A1
(en)
|
2001-05-15 |
2003-01-30 |
Gary Ashley |
Epothilone derivatives and methods for making and using the same
|
|
JP2004532888A
(ja)
|
2001-06-01 |
2004-10-28 |
ブリストル−マイヤーズ スクイブ カンパニー |
エポチロン誘導体
|
|
US6737409B2
(en)
|
2001-07-19 |
2004-05-18 |
Hoffmann-La Roche Inc. |
Dolastatin 10 derivatives
|
|
US20060258581A1
(en)
|
2001-11-21 |
2006-11-16 |
Reed John C |
Methods and composition for derepressions of IAP-inhibited caspase
|
|
AU2002360430A1
(en)
|
2001-11-26 |
2003-06-10 |
Kosan Biosciences, Inc. |
14-methyl-epothilones
|
|
DE10164592A1
(de)
|
2001-12-21 |
2003-07-03 |
Schering Ag |
C1-C6-Epothilon-Fragmente und Verfahren für die Herstellung von C1-C6-Fragmenten von Epothilonen und deren Derivaten
|
|
AU2003212457A1
(en)
|
2002-03-01 |
2003-09-16 |
University Of Notre Dame |
Derivatives of epothilone b and d and synthesis thereof
|
|
WO2003077903A1
(en)
|
2002-03-12 |
2003-09-25 |
Bristol-Myers Squibb Company |
C12-cyano epothilone derivatives
|
|
AU2003231799A1
(en)
|
2002-05-23 |
2003-12-12 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
|
US20060128632A1
(en)
|
2002-07-02 |
2006-06-15 |
Sharma Sushil K |
Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap)
|
|
DE60324964D1
(de)
|
2002-07-15 |
2009-01-08 |
Univ Princeton |
Iap-bindende verbindungen
|
|
DE60334247D1
(de)
|
2002-11-27 |
2010-10-28 |
Irm Llc |
Verfahren und zusammensetzungen zur apoptoseinduktion in krebszellen
|
|
WO2004066958A2
(en)
|
2003-01-30 |
2004-08-12 |
The Trustees Of Princeton University |
Caspase-9:bir3 domain of xiap complexes and methods of use
|
|
DE60322120D1
(de)
*
|
2003-02-07 |
2008-08-21 |
Genentech Inc |
Zusammensetzungen und verfahren für verstärkte apoptose
|
|
CA2553871A1
(en)
|
2004-01-16 |
2005-08-04 |
The Regents Of The University Of Michigan |
Smac peptidomimetics and the uses thereof
|
|
AU2005218555B2
(en)
|
2004-03-01 |
2008-01-03 |
Board Of Regents, The University Of Texas System |
Dimeric small molecule potentiators of apoptosis
|
|
AU2005228950B2
(en)
|
2004-03-23 |
2012-02-02 |
Genentech, Inc. |
Azabicyclo-octane inhibitors of IAP
|
|
WO2005097791A1
(en)
*
|
2004-04-07 |
2005-10-20 |
Novartis Ag |
Inhibitors of iap
|
|
WO2006014361A1
(en)
|
2004-07-02 |
2006-02-09 |
Genentech, Inc. |
Inhibitors of iap
|
|
US7674787B2
(en)
|
2004-07-09 |
2010-03-09 |
The Regents Of The University Of Michigan |
Conformationally constrained Smac mimetics and the uses thereof
|
|
US20100190688A1
(en)
*
|
2004-07-12 |
2010-07-29 |
Bin Chao |
Tetrapeptide analogs
|
|
JP5230865B2
(ja)
|
2004-07-15 |
2013-07-10 |
テトラロジック ファーマシューティカルズ コーポレーション |
Ｉａｐ結合性化合物
|
|
EA019420B1
(ru)
|
2004-12-20 |
2014-03-31 |
Дженентех, Инк. |
Пирролидиновые ингибиторы иап (ингибиторов апоптоза)
|
|
DK1851200T3
(da)
|
2005-02-25 |
2014-04-14 |
Tetralogic Pharm Corp |
Dimere iap-inhibitorer
|
|
US20070003535A1
(en)
|
2005-03-17 |
2007-01-04 |
Reed John C |
Methods and compositions for derepression of IAP-inhibited caspase
|
|
DE102005017116A1
(de)
|
2005-04-13 |
2006-10-26 |
Novartis Ag |
Hemmstoffe für Inhibitoren von Apoptose Proteinen (IAP)
|
|
CA2607940C
(en)
*
|
2005-05-18 |
2009-12-15 |
Aegera Therapeutics Inc. |
Bir domain binding compounds
|
|
AU2006254538A1
(en)
|
2005-05-25 |
2006-12-07 |
2Curex Aps |
Compounds modifying apoptosis
|
|
CA2610396A1
(en)
|
2005-06-08 |
2006-12-14 |
Novartis Ag |
Organic compounds
|
|
WO2007048224A1
(en)
|
2005-10-25 |
2007-05-03 |
Aegera Therapeutics Inc. |
Iap bir domain binding compounds
|
|
CN101374829A
(zh)
|
2005-12-19 |
2009-02-25 |
健泰科生物技术公司 |
Iap的抑制剂
|
|
CN101340947B
(zh)
|
2005-12-20 |
2012-09-05 |
诺瓦提斯公司 |
Iap-抑制剂和紫杉烷7的组合
|
|
WO2007101347A1
(en)
|
2006-03-07 |
2007-09-13 |
Aegera Therapeutics Inc. |
Bir domain binding compounds
|
|
TWI543988B
(zh)
|
2006-03-16 |
2016-08-01 |
科學製藥股份有限公司 |
結合於細胞凋亡抑制蛋白（ｉａｐ）之桿狀病毒ｉａｐ重複序列（ｂｉｒ）區域之化合物
|
|
BRPI0708942A2
(pt)
|
2006-03-21 |
2011-06-14 |
Joyant Pharmaceuticals Inc |
composto promotor de apoptose, uso e mÉtodo de produÇço do mesmo e composiÇço farmacÊutica
|
|
AU2007248473B2
(en)
|
2006-05-05 |
2011-01-27 |
The Regents Of The University Of Michigan |
Bivalent Smac mimetics and the uses thereof
|
|
MY159563A
(en)
|
2006-05-16 |
2017-01-13 |
Pharmascience Inc |
Iap bir domain binding compounds
|
|
JP5452223B2
(ja)
|
2006-07-24 |
2014-03-26 |
テトラロジック ファーマシューティカルズ コーポレーション |
Ｉａｐ阻害剤
|
|
US20100144650A1
(en)
|
2006-07-24 |
2010-06-10 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
EP2049563B1
(en)
|
2006-07-24 |
2014-03-12 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap antagonists
|
|
WO2008014238A2
(en)
|
2006-07-24 |
2008-01-31 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
US20100113326A1
(en)
|
2006-07-24 |
2010-05-06 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
US20100056495A1
(en)
|
2006-07-24 |
2010-03-04 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
PE20110224A1
(es)
|
2006-08-02 |
2011-04-05 |
Novartis Ag |
PROCEDIMIENTO PARA LA SINTESIS DE UN PEPTIDOMIMETICO DE Smac INHIBIDOR DE IAP, Y COMPUESTOS INTERMEDIARIOS PARA LA SINTESIS DEL MISMO
|
|
JP5190062B2
(ja)
|
2006-10-12 |
2013-04-24 |
ノバルティス アーゲー |
Ｉａｐ阻害剤としてのピロリジン誘導体
|
|
KR20090082221A
(ko)
|
2006-10-19 |
2009-07-29 |
노파르티스 아게 |
유기 화합물
|
|
MX2009005551A
(es)
|
2006-11-28 |
2009-06-08 |
Novartis Ag |
Uso de inhibidores de iap para el tratamiento de leucemia mieloide aguda.
|
|
KR20090087094A
(ko)
|
2006-11-28 |
2009-08-14 |
노파르티스 아게 |
Ｉａｐ 억제제 및 ｆｌｔ3 억제제의 조합물
|
|
JP2010512322A
(ja)
|
2006-12-07 |
2010-04-22 |
ノバルティス アーゲー |
有機化合物
|
|
JP2010513561A
(ja)
|
2006-12-19 |
2010-04-30 |
ジェネンテック， インコーポレイテッド |
Ｉａｐのイミダゾピリジンインヒビター
|